{"nct_id":"NCT05626322","title":"Effects of Maplirpacept (PF-07901801),Tafasitamab, and Lenalidomide in People With Relapsed or Refractory Diffuse Large B-cell Lymphoma","status":"TERMINATED","status_verified_date":"2025-09","start_date":"2023-08-04","start_date_type":"ACTUAL","primary_completion_date":"2024-08-12","primary_completion_date_type":"ACTUAL","completion_date":"2025-05-01","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["PFE"]}